These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36399266)

  • 21. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
    Fisher RA; Miners JS; Love S
    Brain Pathol; 2022 Nov; 32(6):e13061. PubMed ID: 35289012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
    Deane R; Zlokovic BV
    Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease.
    Banerjee S; Banerjee S
    Methods Mol Biol; 2024; 2761():355-372. PubMed ID: 38427250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
    Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
    Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease.
    Ahn HJ; Chen ZL; Zamolodchikov D; Norris EH; Strickland S
    Curr Opin Hematol; 2017 Sep; 24(5):427-431. PubMed ID: 28661939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.
    Ahn HJ; Zamolodchikov D; Cortes-Canteli M; Norris EH; Glickman JF; Strickland S
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21812-7. PubMed ID: 21098282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development.
    Röhr D; Boon BDC; Schuler M; Kremer K; Hoozemans JJM; Bouwman FH; El-Mashtoly SF; Nabers A; Großerueschkamp F; Rozemuller AJM; Gerwert K
    Acta Neuropathol Commun; 2020 Dec; 8(1):222. PubMed ID: 33308303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease.
    Miners JS; Schulz I; Love S
    J Cereb Blood Flow Metab; 2018 Jan; 38(1):103-115. PubMed ID: 28151041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.
    Cortes-Canteli M; Paul J; Norris EH; Bronstein R; Ahn HJ; Zamolodchikov D; Bhuvanendran S; Fenz KM; Strickland S
    Neuron; 2010 Jun; 66(5):695-709. PubMed ID: 20547128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
    Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
    EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral amyloid angiopathy-linked β-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen.
    Cajamarca SA; Norris EH; van der Weerd L; Strickland S; Ahn HJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14482-14492. PubMed ID: 32518112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
    Kaya I; Brinet D; Michno W; Syvänen S; Sehlin D; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2017 Feb; 8(2):347-355. PubMed ID: 27984697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
    Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
    Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
    Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
    J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.
    Agyare EK; Leonard SR; Curran GL; Yu CC; Lowe VJ; Paravastu AK; Poduslo JF; Kandimalla KK
    Mol Pharm; 2013 May; 10(5):1557-65. PubMed ID: 23249146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
    Boese AC; Hamblin MH; Lee JP
    Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.